Jason O'Byrne is Chief Financial Officer of Caribou Biosciences, Inc.. Currently has a direct ownership of 59,224 shares of CRBU, which is worth approximately $106,603. The most recent transaction as insider was on Feb 20, 2024, when has been sold 33,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.2K
0% 3M change
143.36% 12M change
Total Value Held $106,603

Jason O'Byrne Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2024
BUY
Grant, award, or other acquisition
-
33,000 Added 35.78%
59,224 Common Stock
Feb 08 2022
BUY
Exercise of conversion of derivative security
$100,021 $4.11 p/Share
24,336 Added 50.0%
24,336 Common Stock

Also insider at

VIR
Vir Biotechnology, Inc. Healthcare
JO

Jason O'Byrne

Chief Financial Officer
Berkeley, CA

Track Institutional and Insider Activities on CRBU

Follow Caribou Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBU shares.

Notify only if

Insider Trading

Get notified when an Caribou Biosciences, Inc. insider buys or sells CRBU shares.

Notify only if

News

Receive news related to Caribou Biosciences, Inc.

Track Activities on CRBU